The latest results suggest that gypenosides may regulate mitochondrial-mediated apoptosis in ApoE−/− mice through the PI3K/Akt/Bad pathways, thus inhibiting atherosclerosis (Song et al., 2020). Here, AKT1 is linked to atherosclerosis.